A detailed history of Seamount Financial Group Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Seamount Financial Group Inc holds 1,500 shares of ABBV stock, worth $290,280. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,500
Previous 1,529 1.9%
Holding current value
$290,280
Previous $278 Million 7.6%
% of portfolio
0.21%
Previous 0.24%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $4,488 - $5,242
-29 Reduced 1.9%
1,500 $257 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $210,390 - $236,949
1,529 New
1,529 $237 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Seamount Financial Group Inc Portfolio

Follow Seamount Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seamount Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Seamount Financial Group Inc with notifications on news.